Serosep /News /Serosep Awarded H2020 Funding

Serosep Awarded H2020 Funding

Sep 20, 2018

Serosep are beginning a feasibility study, identifying an environmentally friendly alternative to revolutionise the use of formaldehyde in The Histopathology (human tissue) fixative market.

This project has received funding from the European Unions Horizon 2020 research and innovation programme under grant agreement no. 809670.

https://cordis.europa.eu/project/rcn/213889_en.html